April 19th 2024
Results published in the journal Ophthalmology find no risk reduction from daily one-gram capsules of omega-3 fatty acids.
How Cataract Surgery Could Be Changed To Reduce Greehouse Gas Emissions and Affect Climate Change
July 18th 2023Medical specialties are beginning to look at the environmental impacts of their areas of medicine. A review published in Ophthalmology homed in on cataract surgery and steps that might be taken to reduce greenhouse gas emissions associated with one of the most commonly performed surgeries.
Read More
Research Uncovers Link Between Complement Factor H Gene and Idiopathic MFC
July 6th 2023Idiopathic multifocal choroiditis is a rare condition that typically occurs in young women with myopia. A genome-wide association study conducted by Dutch researchers identified a genetic variant that is associated with the disease and implicates dysregulation of the complement system as a possible cause.
Read More
Study Identifies Cost Drivers for Different Forms of Endothelial Keratoplasty
June 27th 2023Overall, Descemet membrane endothelial keratoplasty cost less than Descemet stripping automated endothelial keratoplasty and can be done faster, according to findings reported by University of Michigan researchers.
Read More
Two New Therapies for Dry Eye Will Soon be on the Market
June 9th 2023The FDA has approved two novel therapies for patients with dry eye disease: Vevye (previously CyclASol) is a water-free, preservative-free solution, and Miebo, which address the excessive tear evaporation that is seen with dry eye.
Read More
University of Virginia Researchers Discover New Target to Prevent Vision Loss
March 24th 2023The discovery of a protein that determines levels of vascular endothelial growth factor-A (VEGF) could lead to new therapies for macular degeneration, diabetic retinopathy and other common causes of vision loss.
Read More
Eyelea is Shown to Be More Effective Than Avastin at Weaning nvAMD Patients off Treatments
December 8th 2022The early response to neovascular age-related macular degeneration (nvAMD) treatment with aflibercept (Eyelea) was much greater than the response to bevacizumab (Avastin), in hopes of weaning those affected off the therapies sooner.
Read More
Can Ocular Biomarkers Be Used to Diagnose Alzheimer’s Disease?
December 5th 2022In an umbrella review — a review of reviews — investigators found that so far, studies of ocular biomarkers to diagnose Alzheimer’s disease had important limitations. Longitudinal studies that use artificial intelligence could perhaps identify ocular biomarkers, the researchers suggest.
Read More